BioCentury
ARTICLE | Finance

Taiho ups its stakes

Taiho Ventures’ upsized fund will enable the venture arm to take larger stakes

October 19, 2018 8:46 PM UTC

After bumping up its evergreen fund from $50 million to $300 million, Taiho Ventures LLC plans to increase its stakes in its portfolio companies.

The strategic venture arm of Taiho Pharmaceutical Co. Ltd. launched in 2016 to invest in a mix of build-to-buy deals, spinouts from the parent company and traditional venture financings, with a focus on oncology companies that could eventually become business development partners for the pharma (see “Venturing West”). ...